| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21977e40c08969f3e950eb43ecafe0cb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 |
| filingDate |
1993-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a93ce243bc4c79fff97d28af65e3583 |
| publicationDate |
1994-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0590972-A1 |
| titleOfInvention |
Treatment of ocular hypertension with a synergistic combination |
| abstract |
A use of an ocular-hypertension synergistic combination ofn (a) a 15-deoxy-prostaglandin compound, and (b) a β-adrenergic blocker n for the manufacture of a medicament useful in treatment of ocular hypertension. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9763958-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8618093-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9061034-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10058560-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9078854-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5405846-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10045997-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8629140-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8906907-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9474760-B2 |
| priorityDate |
1992-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |